UNC Lineberger patient Morgan Throckmorton talks with WRAL about her diagnosis, clinical trials

UNC Lineberger patient Morgan Throckmorton was diagnosed with colon cancer in 2009 when she was 24 years old. She is now part of a UNC-led trial to test a new drug, Regorafinib.

Morgan Throckmorton

She talks about her diagnosis and treatment and why she wanted to take part in the clinical trial.

Dr. Bert O'Neil, a faculty member in UNC Lineberger's Gastrointestinal Oncology program, talks about the K-RAS mutation - which Throckmorton tested positive for - which is present in about a third of colon cancer cases.

Read more and watch videoIcon indicating that a link will open an external site..